ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
諾誠健華
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
- -
資料載入中...
總覽
公司
新聞
公告
諾誠健華在港交所公告:建議發行人民幣股份及於上海證券交易所科創板上市
界面新闻
·
2021-03-11
諾誠健華-B擬科創板上市
智通财经
·
2021-03-11
諾誠健華-B(09969.HK)建議發行人民幣股份在科創板上市
格隆汇
·
2021-03-11
諾誠健華-B(09969)擬科創板上市
智通财经
·
2021-03-11
諾誠健華-B(09969.HK)3月26日舉行董事會會議審批年度業績
金融界网站
·
2021-03-10
09969--諾誠健華-B:董事會會議日期
同花顺
·
2021-03-10
【異動股】諾誠健華-B(09969-HK)跌4.6%
金融界网站
·
2021-03-08
*瑞銀上調信達生物(01801.HK)目標價至132.9元 降諾誠健華(09969.HK)評級至「中性」(更正)
AAFN
·
2021-03-08
諾誠健華-B盤中異動 早盤股價大跌5.20%
自选股智能写手
·
2021-03-05
諾誠健華(09969.HK)更換首席醫學官
AAFN
·
2021-03-01
諾誠健華-B更換首席醫學官
每日经济新闻
·
2021-03-01
諾誠健華-B(09969.HK)委任張向陽為新首席醫學官
格隆汇
·
2021-03-01
東吳證券:首予諾誠健華(09969.HK)買入評級。
新浪财经
·
2021-02-24
【異動股】諾誠健華-B(09969-HK)跌3.21%
金融界网站
·
2021-02-24
諾誠健華-B(09969-HK)跌3.08%
财华社
·
2021-02-18
港股異動 | 諾誠健華-B(9969.HK)大漲逾13%破頂 市值超330億港元
格隆汇
·
2021-02-16
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/90009/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90009","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","market":"HK","secType":"STK","nameCN":"諾誠健華","latestPrice":0,"timestamp":1748851200000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":25034000,"shares":225290000,"eps":0,"marketStatus":"未開盤","change":0,"latestTime":"06-02 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1748914200000},"marketStatusCode":0,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1748827800000,1748836800000],[1748840400000,1748851200000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"諾誠健華","latestPrice":24.02,"timestamp":1748588400000,"preClose":22.99,"halted":0,"volume":7613700,"delay":0,"premium":"-100.00"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","floatShares":25034000,"roa":"--","roe":"--","lyrEps":0,"shares":225290000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90009\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2118498643","title":"諾誠健華在港交所公告:建議發行人民幣股份及於上海證券交易所科創板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2118498643","media":"界面新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118498643?lang=zh_tw&edition=fundamental","pubTime":"2021-03-11 18:30","pubTimestamp":1615458600,"startTime":"0","endTime":"0","summary":"【快讯】诺诚健华在港交所公告,建议发行人民币股份及于上海证券交易所科创板上市。(界面新闻)","market":"hk","thumbnail":"https://static.tigerbbs.com/f1244793084c6388467f46fc7c39784b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f1244793084c6388467f46fc7c39784b"],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202103111840542937.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202103111840542937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CYB","CNHmain","UCmain","90009"],"gpt_icon":0},{"id":"2118986299","title":"諾誠健華-B擬科創板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2118986299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118986299?lang=zh_tw&edition=fundamental","pubTime":"2021-03-11 18:24","pubTimestamp":1615458286,"startTime":"0","endTime":"0","summary":"诺诚健华-B(09969)发布公告,于2021年3月11日,公司董事会决议公司拟发行人民币股份及于上海证券交易所科创板上市。 ...","market":"sh","thumbnail":"https://static.tigerbbs.com/0dadac519bb6258dbafe32faf8a03d89","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0dadac519bb6258dbafe32faf8a03d89"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20210311/c627697287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["09969","90009"],"gpt_icon":0},{"id":"2118986282","title":"諾誠健華-B(09969.HK)建議發行人民幣股份在科創板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2118986282","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118986282?lang=zh_tw&edition=fundamental","pubTime":"2021-03-11 18:23","pubTimestamp":1615458236,"startTime":"0","endTime":"0","summary":"格隆汇 3 月 11日丨诺诚健华-B(09969.HK)发布公告,2021年3月11日,公司董事会决议公司拟发行人民币股份及于上海证券交易所科创板上市。","market":"us","thumbnail":"https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/news/detail.html?id=494489","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_gelonghui","symbols":["90009","UCmain","CNHmain","09969","CYB"],"gpt_icon":0},{"id":"2118986189","title":"諾誠健華-B(09969)擬科創板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2118986189","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118986189?lang=zh_tw&edition=fundamental","pubTime":"2021-03-11 18:23","pubTimestamp":1615458180,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺诚健华-B(09969)发布公告,于2021年3月11日,公司董事会决议公司拟发行人民币股份及于上海证券交易所科创板上市。","market":"hk","thumbnail":"https://static.tigerbbs.com/b8906c2117cf409a3cc5087f96741bce","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/b8906c2117cf409a3cc5087f96741bce"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/425643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["90009","09969"],"gpt_icon":0},{"id":"2118367955","title":"諾誠健華-B(09969.HK)3月26日舉行董事會會議審批年度業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2118367955","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118367955?lang=zh_tw&edition=fundamental","pubTime":"2021-03-10 20:34","pubTimestamp":1615379642,"startTime":"0","endTime":"0","summary":"格隆汇 3 月 10日丨诺诚健华-B(09969.HK)公告,公司将于2021年3月26日(星期五)举行董事会会议,藉以(其中包括)考虑并批准本公司及其附属公司截至2020年12月31日止年度业绩及其发布。","market":"hk","thumbnail":"https://static.tigerbbs.com/f25970ebf4293eec7586423288711d3f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f25970ebf4293eec7586423288711d3f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/03/10203432105338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09969","90009"],"gpt_icon":0},{"id":"2118042776","title":"09969--諾誠健華-B:董事會會議日期","url":"https://stock-news.laohu8.com/highlight/detail?id=2118042776","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2118042776?lang=zh_tw&edition=fundamental","pubTime":"2021-03-10 20:32","pubTimestamp":1615379551,"startTime":"0","endTime":"0","summary":"原标题:09969--諾健華-B:董事會會議日期 来源:联交所--披露易香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表示,概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。InnoCarePharmaLimited諾健華醫藥有限公司(於開曼群島註冊成立的有限公司)(股份代號:9969)董事會會議","market":"us","thumbnail":"https://static.tigerbbs.com/e9c35ed98221796867ee3eb028c7fe9e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e9c35ed98221796867ee3eb028c7fe9e"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-10/doc-ikknscsi0671432.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2021-03-10/doc-ikknscsi0671432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009"],"gpt_icon":0},{"id":"2117669067","title":"【異動股】諾誠健華-B(09969-HK)跌4.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2117669067","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2117669067?lang=zh_tw&edition=fundamental","pubTime":"2021-03-08 15:24","pubTimestamp":1615188240,"startTime":"0","endTime":"0","summary":"【财华社讯】诺诚健华-B(09969-HK)截至15:24下跌4.6%,现报17港元,跌0.82港元。成交607万股,涉资1.096亿元。(出处:FinetAI)","market":"us","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/03/08152432091123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["90009","09969"],"gpt_icon":0},{"id":"2117165051","title":"*瑞銀上調信達生物(01801.HK)目標價至132.9元 降諾誠健華(09969.HK)評級至「中性」(更正)","url":"https://stock-news.laohu8.com/highlight/detail?id=2117165051","media":"AAFN","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2117165051?lang=zh_tw&edition=fundamental","pubTime":"2021-03-08 10:29","pubTimestamp":1615170563,"startTime":"0","endTime":"0","summary":"(2021-03-08 09:38:31 \t*瑞银上调信达生物 目标价至132.9元 降诺诚健华 评级至「中性」)~阿思达克财经新闻网址: www.aastocks.com","market":"us","thumbnail":"https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1080980&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks","symbols":["01801","90009","09969"],"gpt_icon":0},{"id":"2117883637","title":"諾誠健華-B盤中異動 早盤股價大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2117883637","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2117883637?lang=zh_tw&edition=fundamental","pubTime":"2021-03-05 09:59","pubTimestamp":1614909582,"startTime":"0","endTime":"0","summary":"2021年03月05日早盘09时59分,诺诚健华-B股票出现异动,股价快速下跌5.20%。截至发稿,该股报17.880港元/股,成交量101.5万股,换手率0.07%,振幅3.61%。诺诚健华-B股票所在的生物技术行业中,整体跌幅为7.18%。诺诚健华-B公司简介:诺诚健华医药有限公司是一家主要从事生物医药业务的投资控股公司。消息层面,截至09时59分,诺诚健华-B股票正面舆情新闻比例50%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103050959427dcbfb32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103050959427dcbfb32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","90009"],"gpt_icon":0},{"id":"2116875705","title":"諾誠健華(09969.HK)更換首席醫學官","url":"https://stock-news.laohu8.com/highlight/detail?id=2116875705","media":"AAFN","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2116875705?lang=zh_tw&edition=fundamental","pubTime":"2021-03-01 09:11","pubTimestamp":1614561072,"startTime":"0","endTime":"0","summary":"诺诚健华 公布,公司现任首席医学官徐志新计划於过渡期以及委任新首席医学官後退任其职位,而张向阳已获委任为公司新首席医学官,自今年3月1日起生效。(sw/w)~阿思达克财经新闻网址: www.aastocks.com","market":"us","thumbnail":"https://static.tigerbbs.com/b8906c2117cf409a3cc5087f96741bce","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/b8906c2117cf409a3cc5087f96741bce"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1079179&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks","symbols":["09969","90009"],"gpt_icon":0},{"id":"2116958238","title":"諾誠健華-B更換首席醫學官","url":"https://stock-news.laohu8.com/highlight/detail?id=2116958238","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2116958238?lang=zh_tw&edition=fundamental","pubTime":"2021-03-01 08:13","pubTimestamp":1614557580,"startTime":"0","endTime":"0","summary":"诺诚健华-B(09969,HK)董事会宣布,公司现任首席医学官徐志新博士(徐博士)计划于过渡期以及委任新首席医学官后退任其职位,并将于二零二一年三月一日起生效。张向阳博士已获委任为公司新首席医学官,自...","market":"hk","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":{"source":"stock_eastmoney","url":"http://hk.eastmoney.com/a/202103011824310023.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202103011824310023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09969","90009"],"gpt_icon":0},{"id":"2116584304","title":"諾誠健華-B(09969.HK)委任張向陽為新首席醫學官","url":"https://stock-news.laohu8.com/highlight/detail?id=2116584304","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2116584304?lang=zh_tw&edition=fundamental","pubTime":"2021-03-01 06:25","pubTimestamp":1614551122,"startTime":"0","endTime":"0","summary":"格隆汇 3 月 1日丨诺诚健华-B(09969.HK)发布公告,公司现任首席医学官徐志新博士计划于过渡期以及委任新首席医学官后退任其职位,并将于2021年3月1日起生效。张向阳博士已获委任为公司新首席医学官,自同日起生效。","market":"hk","thumbnail":"https://static.tigerbbs.com/bde7ae9d5c597eb01bbb4658f0573654","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bde7ae9d5c597eb01bbb4658f0573654"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/news/detail.html?id=489312","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_gelonghui","symbols":["09969","90009"],"gpt_icon":0},{"id":"2113229360","title":"東吳證券:首予諾誠健華(09969.HK)買入評級。","url":"https://stock-news.laohu8.com/highlight/detail?id=2113229360","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2113229360?lang=zh_tw&edition=fundamental","pubTime":"2021-02-24 21:26","pubTimestamp":1614173219,"startTime":"0","endTime":"0","summary":"东吴证券:首予诺诚健华(09969.HK)买入评级。","market":"sh","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2021-02-24/doc-ikftpnny9531149.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2021-02-24/doc-ikftpnny9531149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["601555","90009","09969"],"gpt_icon":0},{"id":"2113363678","title":"【異動股】諾誠健華-B(09969-HK)跌3.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2113363678","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2113363678?lang=zh_tw&edition=fundamental","pubTime":"2021-02-24 14:28","pubTimestamp":1614148096,"startTime":"0","endTime":"0","summary":"【财华社讯】诺诚健华-B(09969-HK)截至14:28下跌3.21%,现报19.28港元,跌0.64港元。成交550万股,涉资1.098亿元。(出处:FinetAI)","market":"hk","thumbnail":"https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2021/02/24142832018539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["90009","09969"],"gpt_icon":0},{"id":"2112863874","title":"諾誠健華-B(09969-HK)跌3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2112863874","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2112863874?lang=zh_tw&edition=fundamental","pubTime":"2021-02-18 11:46","pubTimestamp":1613619960,"startTime":"0","endTime":"0","summary":"诺诚健华-B(09969-HK)截至11:43下跌3.08%,现报22港元,跌0.7港元。成交615万股,涉资1.384亿元。","market":"us","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202102181812067216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["90009","09969"],"gpt_icon":0},{"id":"2111439007","title":"港股異動 | 諾誠健華-B(9969.HK)大漲逾13%破頂 市值超330億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2111439007","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2111439007?lang=zh_tw&edition=fundamental","pubTime":"2021-02-16 11:12","pubTimestamp":1613445130,"startTime":"0","endTime":"0","summary":"格隆汇2月16日丨诺诚健华-B(9969.HK)大幅拉升至13.59%,高见22.65港元再创历史新高价,总市值超330亿港元。日前诺诚健华-B已经完成配售2.1亿股,当中高瓴资本认购1.92亿股、维梧资本认购1,889.5万股。预计所得款项净额约30.41亿港元,将用于在国内和国际地区扩大和加速正在进行和计划进行的临床试验。另外,奥布替尼联合治疗临床试验申请获批,诺诚健华董事长兼首席执行官崔霁松表示,目前奥布替尼正在中国及美国进行多中心、多适应症的临床试验。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/news/detail.html?id=484617","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_gelonghui","symbols":["09969","90009"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90009\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90009\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90009\",market:\"HK\",delay:false,,,undefined,":{}}}